Danish researchers have created new cell lines that need a less tailored feeding schedule and produce fewer waste products.

Manufacturing differences between ranibizumab and aflibercept biosimilars might shape pricing, uptake, and patient access globally.

D printing is a good option for bioreactor production. The flexibility of the approach outweighs concerns about higher costs.

Lab-scale production of medicarpin in yeast heralds another manufacturing option for this natural anti-tumor agent.

According to the data, when microglia activity in the brain was suppressed, baby mice were better able to recall fearful experiences.

GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

Data from several dozen human volunteers showed that blocking sEH raised epoxy-oxylipin levels and reduced harmful immune ...

Researchers suggest that wound dressings infused with antioxidants such as catalase could be an effective future treatment.

Scientists first read the human genome, a three-billion-letter biological book, in April 2003. Since then, researchers have steadily advanced the ability to write DNA, moving far beyond single-gene ...

Researchers say the living sensor display technology may have potential applications beyond human healthcare, in veterinary ...